Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
American Journal of Clinical Dermatology
Published in: American Journal of Clinical Dermatology 3/2022

14-02-2022 | Sweet's Syndrome | Review Article

New Practical Aspects of Sweet Syndrome

Authors: Tejas P. Joshi, Sarah K. Friske, David A. Hsiou, Madeleine Duvic

Published in: American Journal of Clinical Dermatology | Issue 3/2022

Login to get access

Abstract

Sweet syndrome (SS), or acute febrile neutrophilic dermatosis, is an inflammatory, non-infectious skin reaction characterized clinically by tender, erythematous papules/plaques/pustules/nodules commonly appearing on the upper limbs, trunk, and head and neck; histologically, SS is characterized by dense neutrophilic infiltrate in the dermis. SS is accompanied by fever; an elevation of inflammatory markers (e.g., erythrocyte sedimentation rate, C reactive protein) in serum may also be observed. Although most cases of SS are idiopathic, SS also occurs in the setting of malignancy or following administration of an associated drug. SS has also been reported in association with pregnancy and a burgeoning list of infectious (most commonly upper respiratory tract infections) and inflammatory diseases; likewise, the litany of possible iatrogenic triggers has also grown. Over the past several years, a wider spectrum of SS presentation has been realized, with several reports highlighting novel clinical and histological variants. Corticosteroids continue to be efficacious first-line therapy for the majority of patients with SS, although novel steroid-sparing agents have been recently added to the therapeutic armamentarium against refractory SS. New mechanisms of SS induction have also been recognized, although the precise etiology of SS still remains elusive. Here, we catalogue the various clinical and histological presentations of SS, summarize recently reported disease associations and iatrogenic triggers, and review treatment options. We also attempt to frame the findings of this review in the context of established and emerging paradigms of SS pathogenesis.
Appendix
Available only for authorised users
Literature
1.
2.
Nelson CA, Stephen S, Ashchyan HJ, James WD, Micheletti RG, Rosenbach M. Neutrophilic dermatoses: Pathogenesis, Sweet syndrome, neutrophilic eccrine hidradenitis, and Behçet disease. J Am Acad Dermatol. 2018;79:987–1006.PubMedCrossRef
3.
Naranjo CA, Busto U, Sellers EM, Sandor P, Ruiz I, Roberts EA, et al. A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther. 1981;30:239–45.PubMedCrossRef
4.
5.
6.
Zheng S, Li S, Tang S, Pan Y, Ding Y, Qiao J, et al. Insights into the characteristics of sweet syndrome in patients with and without hematologic malignancy. Front Med (Lausanne). 2020;7:20.PubMedPubMedCentralCrossRef
7.
Nelson CA, Noe MH, McMahon CM, Gowda A, Wu B, Ashchyan HJ, et al. Sweet syndrome in patients with and without malignancy: a retrospective analysis of 83 patients from a tertiary academic referral center. J Am Acad Dermatol. 2018;78:303-309.e4.PubMedCrossRef
8.
Dan H, Yanmei L, Yue X, Xian J. Sweet syndrome associated with malignancies: a retrospective analysis of 25 patients from West China hospital. Dermatol Ther. 2020;33:e13588.PubMedCrossRef
9.
Wallach AI, Magro CM, Franks AG, Shapiro L, Kister I. Protean neurologic manifestations of two rare dermatologic disorders: sweet disease and localized craniofacial scleroderma. Curr Neurol Neurosci Rep. 2019;19:11.PubMedCrossRef
10.
Amouri M, Masmoudi A, Ammar M, Boudaya S, Khabir A, Boudawara T, et al. Sweet’s syndrome: a retrospective study of 90 cases from a tertiary care center. Int J Dermatol. 2016;55:1033–9.PubMedCrossRef
11.
Rochet NM, Chavan RN, Cappel MA, Wada DA, Gibson LE. Sweet syndrome: clinical presentation, associations, and response to treatment in 77 patients. J Am Acad Dermatol. 2013;69:557–64.PubMedCrossRef
12.
Halpern J, Salim A. Pediatric sweet syndrome: case report and literature review. Pediatr Dermatol. 2009;26:452–7.PubMedCrossRef
13.
Jagati A, Shrivastava S, Baghela B, Agarwal P, Saikia S. Acquired cutis laxa secondary to Sweet syndrome in a child (Marshall syndrome): a rare case report. J Cutan Pathol. 2020;47:146–9.PubMedCrossRef
14.
Stepien AL, Perniciaro C, Kwong P, Rosario-Collazo J, Krishnamurthy K. Infantile histiocytoid Sweet syndrome without an underlying systemic association. JAAD Case Rep. 2021;17:96–9.PubMedPubMedCentralCrossRef
15.
Aghababaie A, Patey R. A case of likely acute febrile neutrophilic dermatosis in a 17-year-old male presenting to general paediatrics. BMJ Case Rep. 2020;13:e233309.PubMedCrossRef
16.
17.
Miranda E, Meza R, Kolbach M, Torres J, Harris PR. Sweet syndrome in pediatric active ulcerative colitis. Am J Gastroenterol. 2021;116:234.PubMedCrossRef
18.
AlRayes J, Al-Sabah H, Fekry A, Nanda A. Progressive erythematous papules and plaques in an infant. Clin Exp Dermatol. 2020;45:235–7.PubMedCrossRef
19.
Webber L, Cummins M, Mann R, Shaw L, Ghinai R, Mahon C. Panniculitis in a 3-year-old child with Fanconi anemia-associated bone marrow hypoplasia heralds transformation to acute myeloid leukemia. Pediatr Dermatol. 2019;36:725–7.PubMedCrossRef
20.
21.
Bucchia M, Barbarot S, Reumaux H, Piram M, Mahe E, Mallet S, et al. Age-specific characteristics of neutrophilic dermatoses and neutrophilic diseases in children. J Eur Acad Dermatol Venereol. 2019;33:2179–87.PubMedCrossRef
22.
Turner M, Chauhan K. Subcutaneous sweet syndrome presenting as cellulitis in a pregnant female. Cureus. 2021;13:e17999.PubMedPubMedCentral
23.
Smolovic BD, Gajic-Veljic MD, Nikolic MM, Muhovic DF. Pregnancy-induced sweet’s syndrome treated with infliximab. Med Princ Pract. 2019;28:196–8.PubMedCrossRef
24.
25.
26.
27.
Errichetti E, Stinco G. Dermatoscopy in life-threatening and severe acute rashes. Clin Dermatol. 2020;38:113–21.PubMedCrossRef
28.
Su WP, Liu HN. Diagnostic criteria for Sweet’s syndrome. Cutis. 1986;37:167–74.PubMed
29.
von den Driesch P. Sweet’s syndrome (acute febrile neutrophilic dermatosis). J Am Acad Dermatol. 1994;31:535–56 (quiz 557–560).PubMedCrossRef
30.
Peteln I, Dolenc-Voljč M, Jurčić V. Neutrophilic dermatosis of the dorsal hands (acral Sweet syndrome) with predominantly lymphocytic dermal infiltrate. J Cutan Pathol. 2020;47:104–7.PubMedCrossRef
31.
Panigrahi A, Biswas SK, Sil A, Bhanja DB. Neutrophilic dermatosis of the hands with palmar involvement and predominant lymphomononuclear cell infiltration. Indian J Dermatol. 2021;66:191–4.PubMedPubMedCentralCrossRef
32.
Borda LJ, Kallis PJ, Pavlis J, Alqatari M, Romanelli P, Yosipovitch G. Sweet syndrome with marked eosinophilic infiltrate. Cutis. 2020;105:E4-6.PubMed
33.
Walker DC, Cohen PR. Trimethoprim-sulfamethoxazole-associated acute febrile neutrophilic dermatosis: case report and review of drug-induced Sweet’s syndrome. J Am Acad Dermatol. 1996;34:918–23.PubMedCrossRef
34.
Chen O, Partarrieu-Mejías F, Alarcón-Cabrera R. Erythema and bullae on the face and hands of a farm worker. Clin Exp Dermatol. 2019;44:99–101.PubMedCrossRef
35.
Giannoni M, Rizzetto G, Sapigni C, Paolinelli M, Tagliati C, Diotallevi F, et al. Bullous Sweet’s syndrome in a patient with ulcerative colitis: a rare case report. Acta Dermatovenerol Alp Pannonica Adriat. 2020;29:153–5.PubMed
36.
Esposito I, Fossati B, Peris K, De Simone C. A rare case of bullous Sweet’s syndrome in a patient with inactive ulcerative colitis. J Eur Acad Dermatol Venereol. 2019;33:e380–1.PubMedCrossRef
37.
Knöpfel N, Theiler M, Luchsinger I, Hafner B, Brunner C, Kolm I, Weibel L. Infliximab for the treatment of recalcitrant bullous Sweet syndrome in a 10-year-old girl. Pediatr Dermatol. 2020;37(6):1183–4.PubMedCrossRef
38.
Sherban A, Fuller C, Sethi M, McGeehin E, Hirokawa D, Guerrieri C, et al. Bullous hemorrhagic Sweet syndrome with cryptococcoid neutrophils in patients positive for antineutrophil cytoplasmic antibody without primary vasculitis. JAAD Case Rep. 2020;6:1196–200.PubMedPubMedCentralCrossRef
39.
Mitaka H, Jammal R, Saabiye J, Yancovitz S, Perlman DC. Giant cellulitis-like Sweet syndrome: an underrecognized clinical variant mimicking skin and soft tissue infection. IDCases. 2020;21:e00874.
40.
Okuyama S, Nito T, Yanagawa N, Tajima K. Giant cellulitis-like Sweet syndrome as an initial clinical presentation of acute myeloblastic leukemia with t(6;9)(p23;q34): DEK-CAN and internal duplications of FMS-like tyrosine kinase 3. Ann Hematol. 2019;98:787–8.PubMedCrossRef
41.
Canal Garcia E, Vargas Ramos JDP, Aguayo OR. Cellulitis-like Sweet syndrome caused by adalimumab therapy for severe hidradenitis suppurativa. Australas J Dermatol. 2020;61:e448–9.PubMedCrossRef
42.
Kroshinsky D, Alloo A, Rothschild B, Cummins J, Tan J, Montecino R, et al. Necrotizing Sweet syndrome: a new variant of neutrophilic dermatosis mimicking necrotizing fasciitis. J Am Acad Dermatol. 2012;67:945–54.PubMedCrossRef
43.
Sanchez IM, Lowenstein S, Johnson KA, Babik J, Haag C, Keller JJ, et al. Clinical features of neutrophilic dermatosis variants resembling necrotizing fasciitis. JAMA Dermatol. 2019;155:79–84.PubMedCrossRef
44.
Paul S, Jammal N, Akhave N, Aung PP, Loghavi S, Jain N, et al. Atypical cases of necrotizing sweet syndrome in patients with myelodysplastic syndrome and acute myeloid leukaemia. Br J Haematol. 2020;191:e10–3.PubMedCrossRef
45.
Anand A, Gentile T, Kato H, Wang Q. Recurrent soft tissue inflammation, necrotizing fascitis or Sweet syndrome, diagnostic dilemma. Clin Case Rep. 2019;7:2483–7.PubMedPubMedCentralCrossRef
46.
Gowda A, Christensen L, Polly S, Barlev D. Necrotizing neutrophilic dermatosis: a diagnostic challenge with a need for multi-disciplinary recognition, a case report. Ann Med Surg (Lond). 2020;57:299–302.PubMedPubMedCentralCrossRef
47.
Miyagami T, Suyama Y, Takahashi Y, Yang K-S, Naito T. Man with thigh pain. Ann Emerg Med. 2020;75:305–8.PubMedCrossRef
48.
Husted A, Udholm S, Udholm N. Necrotising Sweet’s syndrome: a rare presentation of Sweet’s syndrome with unilateral painful swelling of the neck. BMJ Case Rep. 2021;14:e244179.PubMedCrossRef
49.
Strutton G, Weedon D, Robertson I. Pustular vasculitis of the hands. J Am Acad Dermatol. 1995;32:192–8.PubMedCrossRef
50.
Galaria NA, Junkins-Hopkins JM, Kligman D, James WD. Neutrophilic dermatosis of the dorsal hands: pustular vasculitis revisited. J Am Acad Dermatol. 2000;43:870–4.PubMedCrossRef
51.
Micallef D, Bonnici M, Pisani D, Boffa MJ. Neutrophilic dermatosis of the dorsal hands: a review of 123 cases. J Am Acad Dermatol. 2019;S0190–9622(19):32678–87.
52.
Arandes-Marcocci J, Altemir-Vidal A, Iglesias-Plaza A, Fernández-Figueras MT, Salleras-Redonnet M. Neutrophilic dermatosis of the hands with palmar involvement: does it have clinical implication? Int J Dermatol. 2020;59:736–8.PubMedCrossRef
53.
Mobini N, Sadrolashrafi K, Michaels S. Neutrophilic dermatosis of the dorsal hands: report of a case and review of the literature. Case Rep Dermatol Med. 2019;2019:8301585.PubMedPubMedCentral
54.
Phillips D, Cohen SN, Muttoni EMU, Low SE, Ngan K. Necrotic ulceration of the hand case review: think beyond infection. J Emerg Nurs. 2021;47:379–83.PubMedCrossRef
55.
Gloor AD, Feldmeyer L, Borradori L. Neutrophilic dermatosis of the dorsal hands triggered by mechanical trauma. J Eur Acad Dermatol Venereol. 2021;35:e20–1.PubMedCrossRef
56.
57.
Ko JS, Fernandez AP, Anderson KA, Burdick LM, Billings SD, Procop GW, et al. Morphologic mimickers of Cryptococcus occurring within inflammatory infiltrates in the setting of neutrophilic dermatitis: a series of three cases highlighting clinical dilemmas associated with a novel histopathologic pitfall. J Cutan Pathol. 2013;40:38–45.PubMedCrossRef
58.
Wilson J, Gleghorn K, Kelly B. Cryptococcoid Sweet’s syndrome: two reports of Sweet’s syndrome mimicking cutaneous cryptococcosis. J Cutan Pathol. 2017;44:413–9.PubMedCrossRef
59.
Mazzei ME, Guerra A, Dufrechou L, Vola M. Cryptococcoid Sweet syndrome: a clinical and histologic imitator of cryptococcosis. Actas Dermosifiliogr (Engl Ed). 2021;112:79–80.PubMedCrossRef
60.
Requena L, Kutzner H, Palmedo G, Pascual M, Fernández-Herrera J, Fraga J, et al. Histiocytoid Sweet syndrome: a dermal infiltration of immature neutrophilic granulocytes. Arch Dermatol. 2005;141:834–42.PubMedCrossRef
61.
Haber R, Feghali J, El Gemayel M. Risk of malignancy in histiocytoid Sweet syndrome: a systematic review and reappraisal. J Am Acad Dermatol. 2020;83:661–3.PubMedCrossRef
62.
Alegría-Landa V, Rodríguez-Pinilla SM, Santos-Briz A, Rodríguez-Peralto JL, Alegre V, Cerroni L, et al. Clinicopathologic, immunohistochemical, and molecular features of histiocytoid Sweet syndrome. JAMA Dermatol. 2017;153:651–9.PubMedPubMedCentralCrossRef
63.
Kiyohara T, Shimada S, Ohnishi S, Miyamoto M, Shijimaya T, Nagano N, et al. Idiopathic histiocytoid Sweet syndrome with a butterfly rash-like appearance: a confusing case histologically mimicking rosacea-like dermatitis. J Dermatol. 2020;47:e14–5.PubMed
64.
65.
Sano Y, Moriki M, Yagi H, Tokura Y. Photoinduced histiocytoid Sweet’s syndrome. J Dermatol. 2019;46:e378–80.PubMedCrossRef
66.
67.
Miura T, Misa K, Yamamoto T. Subcutaneous Sweet syndrome mimicking cellulitis in a patient with myelodysplastic syndrome and subsequent secondary pulmonary alveolar proteinosis. Clin Exp Dermatol. 2020;45:763–4.PubMedCrossRef
68.
Vargas-Mora P, Valenzuela F, Kaplan V, Carreño L. Subcutaneous Sweet’s syndrome associated with the onset of Behcet’s disease. An Bras Dermatol. 2021;96:644–5.PubMedPubMedCentralCrossRef
69.
Kamimura A, Yanagisawa H, Tsunemi Y, Kusano T, Arai E, Tsuchida T, et al. Normolipemic xanthomatized Sweet’s syndrome: A variant of Sweet’s syndrome with myelodysplastic syndrome. J Dermatol. 2021;48:695–8.PubMedCrossRef
70.
So JK, Carlos CA, Frucht CS, Cohen PR. Histiocytoid giant cellulitis-like Sweet’s syndrome: case report and review of the literature. Dermatol Online J. 2015;21:13030/qt0682f5wp.
71.
Pătraşcu V, Geoloaica LG, Ciurea RN. Recurrent idiopathic Sweet syndrome—case report and literature review. Curr Health Sci J. 2020;46:90–8.PubMedPubMedCentral
72.
Burke N, Saikaly SK, Motaparthi K, Bender NR. Malignancy-associated Sweet syndrome presenting with simultaneous histopathologic and morphologic variants. JAAD Case Rep. 2021;14:104–7.PubMedPubMedCentralCrossRef
73.
Wallach D, Vignon-Pennamen M-D. Pyoderma gangrenosum and Sweet syndrome: the prototypic neutrophilic dermatoses. Br J Dermatol. 2018;178:595–602.PubMedCrossRef
74.
Hisanaga K, Hosokawa M, Sato N, Mochizuki H, Itoyama Y, Iwasaki Y. “Neuro-sweet disease”: benign recurrent encephalitis with neutrophilic dermatosis. Arch Neurol. 1999;56:1010–3.PubMedCrossRef
75.
Hiraga A, Ozaki D, Oikawa M, Araki N, Kuwabara S. Recurrent neurological episodes for 10 years preceding skin lesions in neuro-sweet disease. Intern Med. 2019;58:3469–72.PubMedPubMedCentralCrossRef
76.
Mitamura K, Yamamoto Y, Norikane T, Takata T, Nishiyama Y. Evaluation of the therapeutic response by 11C-methionine PET in a case of neuro-sweet disease. Clin Nucl Med. 2020;45:962–4.PubMedCrossRef
77.
Kusaka H, Nagatani K, Sato T, Minota S. Increase of a wide range of bioactive substances in an active phase of neuro-Sweet disease. BMJ Case Rep. 2020;13:e233457.PubMedPubMedCentralCrossRef
78.
79.
Hoffmann E, Boßelmann C, Forchhammer S, Lerche H, Freilinger T. Neuro-Sweet syndrome—a rare differential diagnosis in aseptic meningoencephalitis. Neurol Res Pract. 2019;1:36.PubMedPubMedCentralCrossRef
80.
Cohen PR, Talpaz M, Kurzrock R. Malignancy-associated Sweet’s syndrome: review of the world literature. J Clin Oncol. 1988;6:1887–97.PubMedCrossRef
81.
Kemmett D, Hunter JA. Sweet’s syndrome: a clinicopathologic review of twenty-nine cases. J Am Acad Dermatol. 1990;23:503–7.PubMedCrossRef
82.
Sitjas D, Puig L, Cuatrecasas M, De Moragas JM. Acute febrile neutrophilic dermatosis (Sweet’s syndrome). Int J Dermatol. 1993;32:261–8.PubMedCrossRef
83.
Gunawardena DA, Gunawardena KA, Ratnayaka RM, Vasanthanathan NS. The clinical spectrum of Sweet’s syndrome (acute febrile neutrophilic dermatosis)—a report of eighteen cases. Br J Dermatol. 1975;92:363–73.PubMedCrossRef
84.
Gottlieb CC, Mishra A, Belliveau D, Green P, Heathcote JG. Ocular involvement in acute febrile neutrophilic dermatosis (Sweet syndrome): new cases and review of the literature. Surv Ophthalmol. 2008;53:219–26.PubMedCrossRef
85.
86.
Wang W, Wang X, Zhao H, Cui Y. A case report of sweet’s syndrome with panuveitis and rhegmatogenous retinal detachment. Ocul Immunol Inflamm. 2021;29:1345–7.PubMedCrossRef
87.
Aghazadeh H, Sia D, Ehmann D. Central retinal artery occlusion associated with Sweet syndrome. Can J Ophthalmol. 2021;56:e103–5.PubMedCrossRef
88.
Guzmán-Almagro E, Fernández-Hortelano A, Díaz-Menéndez A, González-Martín-Moro J. Ocular involvement in a patient with Sweet syndrome: report of a case and review of the literature. Arch Soc Esp Oftalmol (Engl Ed). 2020;95:550–4.PubMedCrossRef
89.
Güemes-Villahoz N, Rodríguez-Quet O, Díaz-Valle D. Acute exaggerated meibomitis as initial manifestation of Sweet syndrome. Ophthalmology. 2020;127:1036.PubMedCrossRef
90.
91.
92.
Manglani R, Jilani N, Raji M, Epelbaum O. Pulmonary involvement in Sweet’s syndrome. Am J Respir Crit Care Med. 2021;204(10):1222–3.PubMedCrossRef
93.
Mizes A, Khosravi H, Bordelon J, Kazlouskaya V, Karunamurthy A, Ho J, et al. Sweet syndrome with pulmonary involvement in a patient with myelodysplastic syndrome. Dermatol Online J. 2020;26:13030/qt1n73f6k5.
94.
95.
Stiller RH, Gadzhiev M, Schachtel AK, Chang OH, Bastawrous S, Hermes Shantz H, et al. A 68-year-old man with skin rash and a pleural effusion. Chest. 2020;158:e33–6.PubMedCrossRef
96.
You YS, Park SW, Yun SK, Lee EJ. Bilateral sudden sensorineural hearing loss with Sweet syndrome: a case report. Medicine (Baltimore). 2020;99:e22127.CrossRef
97.
98.
Graça-Santos L, Kieselova K, Montenegro-Sá F, Guardado J, Morais J. Myocardial involvement in sweet syndrome: a rare finding in a rare condition. Arq Bras Cardiol. 2020;115:6–9.PubMedPubMedCentralCrossRef
99.
Shimagaki H, Kabata Y, Nakamura A, Takei S, Takei I, Kimura K, et al. Neutrophilic myositis with Sweet’s syndrome leading to rhabdomyolysis: a case report. J Dermatol. 2020;47:e415–7.PubMed
100.
Inamadar AC, Adya KA. The rash with painful and erythematous nodules. Clin Dermatol. 2019;37:129–35.PubMedCrossRef
101.
Deutsch A, Jacobson M, McLellan BN. Cutaneous adult T-cell leukemia/lymphoma presenting as sweet syndrome. Acta Oncol. 2020;59:334–5.PubMedCrossRef
102.
Pawar M, Zawar V, Kumavat S. Borderline tuberculoid leprosy in erythema nodosum leprosum reaction mimicking sweet’s syndrome. Actas Dermosifiliogr (Engl Ed). 2021;112:75–7.PubMedCrossRef
103.
Chavez-Alvarez S, Herz-Ruelas M, Ocampo-Candiani J, Gomez-Flores M. Type 2 leprosy reaction resembling Sweet syndrome: review of new and published cases. Australas J Dermatol. 2020;61:e234–7.PubMed
104.
Savitha B, Sardana K, Kumari R, Khurana A, Sinha S, Sachdeva S. Case report: rapid response to low-dose thalidomide in a case of severe steroid recalcitrant erythema nodosum leprosum. Am J Trop Med Hyg. 2021;106:51–3.PubMedCrossRef
105.
Quek CWN, Foong YW, Tan SK, Soh SY, Tan PL, Koh MJA. Leukemia cutis in a child with juvenile myelomonocytic leukemia presenting with Sweet syndrome-like lesions and a history of multiple juvenile xanthogranulomas. JAAD Case Rep. 2020;6:1138–40.PubMedPubMedCentralCrossRef
106.
Hobbs LK, Carr PC, Gru AA, Flowers RH. Case and review: cutaneous involvement by chronic neutrophilic leukemia vs Sweet syndrome—a diagnostic dilemma. J Cutan Pathol. 2021;48:644–9.PubMedCrossRef
107.
Shimizu Y, Nakagawa Y, Kotobuki Y, Kimura K, Hagiya H, Katayama I. Case of Mycobacterium haemophilum infection presenting with Sweet’s syndrome-like reactions. J Dermatol. 2019;46:e319–20.PubMedCrossRef
108.
Ha D-L, Shin K, Kim H-S, Ko H-C, Kim B-S, Kim M-B. A case of vesicobullous rheumatoid neutrophilic dermatosis. J Clin Rheumatol. 2021;27:e118–9.PubMedCrossRef
109.
Sirka CS, Rout AN, Sahu K. Secondary syphilis with polymorphous and sweet syndrome like lesions: a rare case report. Indian Dermatol Online J. 2020;11:409–12.PubMedPubMedCentralCrossRef
110.
Sayeed S, Imtiaz A, Naz F. SAPHO syndrome in an adult male with ulcerative colitis. J Coll Physicians Surg Pak. 2019;29:671–3.PubMedCrossRef
111.
Garcia A, Asad U, Sturgeon A, Tarbox M. Ulcerated zosteriform nodules in adenocarcinoma of the colon. Proc (Bayl Univ Med Cent). 2020;33:637–8.PubMedPubMedCentral
112.
Kazmi SM, Pemmaraju N, Patel KP, Cohen PR, Daver N, Tran KM, et al. Characteristics of Sweet syndrome in patients with acute myeloid leukemia. Clin Lymphoma Myeloma Leuk. 2015;15:358–63.PubMedCrossRef
113.
Berger T, Sherman S, Hayman L, Wolach O, Shacham-Abulafia A, Raanani P, et al. Skin biopsies in acute myeloid leukemia patients undergoing intensive chemotherapy are safe and effect patient management. Sci Rep. 2021;11:11940.PubMedPubMedCentralCrossRef
114.
Merlant M, Lepelletier C, Battistella M, Vignon-Pennamen M-D, Duriez P, Moguelet P, et al. Acute myeloid leukemia and myelodysplastic syndrome-associated Sweet syndrome: a comparative multicenter retrospective study of 39 patients. J Am Acad Dermatol. 2021;84:838–40.PubMedCrossRef
115.
116.
Shah PR, Scott G, Beck LA. Image Gallery: hairy-cell leukaemia presenting with Sweet syndrome. Br J Dermatol. 2019;180:e3.PubMedCrossRef
117.
Thebo U, Tummala S, Nassereddine S, Haroun F. An atypical presentation of Sweet’s syndrome in a myelofibrosis patient. BMJ Case Rep. 2019;12:e228076.PubMedPubMedCentralCrossRef
118.
Kelly L, Justine S, Brandon G, Sandra H, Gwyn R. Sweet syndrome with bitter outcomes in cervical cancer: a case report. Gynecol Oncol Rep. 2021;36:100749.PubMedPubMedCentralCrossRef
119.
Lemaire CC, Portilho ALC, Pinheiro LV, Vivas RA, Britto M, Montenegro M, et al. Sweet syndrome as a paraneoplastic manifestation of cholangiocarcinoma: a case report. World J Clin Cases. 2020;8:4122–7.PubMedPubMedCentralCrossRef
120.
Chirasuthat P, Triyangkulsri K, Rutnin S, Chanprapaph K, Vachiramon V. Cutaneous nontuberculous mycobacterial infection in Thailand: a 7-year retrospective review. Medicine (Baltimore). 2020;99:e19355.CrossRef
121.
Vithoosan S, Thanushah B, Piranavan P, Gamlaksha D, Karunatilake H, Jayanaga A. A rare case of Sweet syndrome secondary to melioidosis. BMC Dermatol. 2019;19:16.PubMedPubMedCentralCrossRef
122.
Kiratikanon S, Thongwitokomarn H, Chaiwarith R, Salee P, Mahanupab P, Jamjanya S, et al. Sweet syndrome as a cutaneous manifestation in a patient with Erysipelothrix rhusiopathiae bacteremia: a case report. IDCases. 2021;24:e01148.
123.
Fania L, Ruggeri S, Sordi D, Oliva A, Provini A, Ricci F, et al. Sweet syndrome following a positive Mantoux test due to pulmonary tuberculosis. Dermatol Ther. 2019;32:e12754.PubMedCrossRef
124.
Escanilla C, Goldman Y, Bobadilla F, Segovia L. Sweet syndrome associated with secondary nodular syphilis in an immunocompetent patient. An Bras Dermatol. 2021;96:319–23.PubMedPubMedCentralCrossRef
125.
Mishal J, Viner I, Livoff A, Maayan S, Magen E. Sweet syndrome and secondary syphilis in a person with acute necrotizing tonsillitis. Case Rep Dermatol. 2021;13:216–21.PubMedPubMedCentralCrossRef
126.
Sharma R, Johnson RH, Heidari A, Malerich M, Stull WR, Cobos E. Neutrophilic dermatosis in myelodysplastic syndrome and chronic active hepatitis C. J Investig Med High Impact Case Rep. 2021;9:23247096211037456.
127.
Mudroch SM, Rohan C, Conger NG, Lindholm DA. Sweet syndrome in an elderly man with well-controlled human immunodeficiency virus. Cureus. 2020;12:e10330.PubMedPubMedCentral
128.
Dong R-J, Huang S-Z, Upadhyay P, Shrestha S, Zhai Y-J, Li Y-Y. Thalidomide in the treatment of Sweet’s syndrome and eosinophilic folliculitis associated with immune reconstitution inflammatory syndrome. Front Med (Lausanne). 2019;6:343.PubMedCrossRef
129.
Taşkın B, Vural S, Altuğ E, Demirkesen C, Kocatürk E, Çelebi İ, et al. Coronavirus 19 presenting with atypical Sweet’s syndrome. J Eur Acad Dermatol Venereol. 2020;34:e534–5.PubMedCrossRef
130.
Berro S, Calas A, Sohier P, Darbord D, Dupin N. Sweet’s syndrome three weeks after a severe COVID-19 infection: a case report. Acta Derm Venereol. 2021;101:00486.CrossRef
131.
Agharbi F-Z, Oqbani K, Allaoui A, Chikhaoui I, Chiheb S. Sweet syndrome in post-COVID-19 infection: a case report. Travel Med Infect Dis. 2021;44:102188PubMedPubMedCentralCrossRef
132.
de Lima ÍMF, Ferraz CE, Gonçalves de Lima-Neto R, Takano DM. Case report: sweet syndrome in patients with sporotrichosis: a 10-case series. Am J Trop Med Hyg. 2020;103:2533–8.
133.
Kaur M, King S, Fotouhie A, Zangeneh TT. Unusual presentations of coccidioidomycosis in conjunction with autoimmune syndromes: a literature review and case series. J Clin Rheumatol. 2020;26:e43–7.PubMedCrossRef
134.
Yan G, Tan KB, Chandran NS, Chai L, Chew KL, Somani J, et al. Histoplasmosis presenting with Sweet’s syndrome. Clin Microbiol Infect. 2020;26:795–6.PubMedCrossRef
135.
Matsuzawa Y, Adachi E, Takahashi A, Sato H, Lim LA, Komatsu T, et al. Cytokine profile in Sweet’s syndrome under the treatment of pulmonary toxoplasmosis complicated with myelodysplastic syndrome. Intern Med. 2019;58:2079–83.PubMedPubMedCentralCrossRef
136.
137.
Okamoto M, Hayashi S, Ikegami T, Kaminaga T, Hamasaki Y, Igawa K. Development of Sweet’s syndrome and the immunological finding of systemic lupus erythematosus during the course of mixed connective tissue disease. Int J Dermatol. 2021;60:e107–8.PubMedCrossRef
138.
Filippi F, Chessa MA, Patrizi A, Baraldi C, Ferrara F, Bardazzi F. Tocilizumab-induced sweet syndrome in a patient with polymyalgia rheumatica. Dermatol Pract Concept. 2020;10:e2020019.PubMed
139.
Baliu-Piqué C, Nogués-Antich E, Cucurell-Palomas M, Grados D. Neutrophilic dermatosis of the hands (Sweet syndrome of the hands) associated with rheumatoid arthritis. Reumatol Clin (Engl Ed). 2019;15:372.PubMedCrossRef
140.
Paul P, Walker CP, Paul M, Dey D. Sweet’s syndrome in a patient with seropositive rheumatoid arthritis after starting adalimumab: is sweet’s syndrome related to rheumatoid arthritis or is it the paradoxical effect of adalimumab? Cureus. 2021;13:e16804.PubMedPubMedCentral
141.
Nousari Y, Wu BC, Valenzuela G. Successful use of baricitinib in the treatment of refractory rheumatoid arthritis-associated Sweet syndrome. Clin Exp Dermatol. 2021;46:1330–2.PubMedCrossRef
142.
Manzo C, Pollio N, Natale M. Sweet’s syndrome following therapy with hydroxychloroquine in a patient affected with elderly-onset primary Sjogren’s syndrome. Medicines (Basel). 2019;6:E111.PubMedCrossRef
143.
Das A, Burmeister R, Chhaya R, Eisenga B, Kumar A. Sweet syndrome in a patient with systemic lupus erythematosus. J Clin Rheumatol. 2020;26:e85–6.PubMedCrossRef
144.
Murphy K, Morrison L, McGOLDRICK J. Sweet syndrome in eosinophilic granulomatosis with polyangiitis. J Rheumatol. 2020;47:1031–2.PubMedCrossRef
145.
Goodwin J, Ives S, Hashmi H. Sweet syndrome and hashimoto thyroiditis: a case report and review of the literature. AACE Clin Case Rep. 2020;6:e179–82.PubMedPubMedCentralCrossRef
146.
Cook QS, Zdanski CJ, Burkhart CN, Googe PB, Thompson P, Wu EY. Idiopathic, refractory Sweet’s syndrome associated with common variable immunodeficiency: a case report and literature review. Curr Allergy Asthma Rep. 2019;19:32.PubMedCrossRef
147.
148.
Giraudo F, Miraglia E, Garbi ML, Yantorno M, Maradeo MR, Correa GJ, et al. Prevalence of pyoderma gangrenosum and Sweet´s syndrome in inflammatory bowel disease at a tertiary healthcare center. Rev Esp Enferm Dig. 2021;113:691–7.PubMed
149.
Sleiman J, Hitawala AA, Cohen B, Falloon K, Simonson M, Click B, et al. Systematic review: Sweet syndrome associated with inflammatory bowel disease. J Crohns Colitis. 2021;15:1864–76.PubMedPubMedCentralCrossRef
150.
Giannese D, Ferro F, Moriconi D, Bonadio AG, Elefante E, Egidi MF, et al. Use of tocilizumab in amyloid a nephropathy associated with Sweet syndrome: a case report and literature review. CEN Case Rep. 2021;10:23–9.PubMedCrossRef
151.
152.
Gkrouzman E, Chirch L, Lakshminarayanan S. Drug-induced Sweet syndrome in a man with sarcoidosis: are there any common mechanisms of pathogenesis? J Clin Rheumatol. 2019;25:e122–6.PubMedCrossRef
153.
Cohen PR, Kurzrock R. Sweet’s syndrome: a review of current treatment options. Am J Clin Dermatol. 2002;3:117–31.PubMedCrossRef
154.
Cerejeira A, Amoedo P, Coelho AR, Silva R, Pedrosa A, Nogueira A, et al. Recurrent Sweet syndrome presenting in a figurate pattern in a patient with Fanconi anemia. Int J Dermatol. 2021.
155.
Jeanfils S, Joly P, Young P, Le Corvaisier-Pieto C, Thomine E, Lauret P. Indomethacin treatment of eighteen patients with Sweet’s syndrome. J Am Acad Dermatol. 1997;36:436–9.PubMedCrossRef
156.
Maillard H, Leclech C, Peria P, Avenel-Audran M, Verret JL. Colchicine for Sweet’s syndrome. A study of 20 cases. Br J Dermatol. 1999;140:565–6.PubMedCrossRef
157.
Horio T, Imamura S, Danno K, Furukawa F, Ofuji S. Treatment of acute febrile neutrophilic dermatosis (Sweet’s syndrome) with potassium iodide. Dermatologica. 1980;160:341–7.PubMedCrossRef
158.
Horio T, Danno K, Okamoto H, Miyachi Y, Imamura S. Potassium iodide in erythema nodosum and other erythematous dermatoses. J Am Acad Dermatol. 1983;9:77–81.PubMedCrossRef
159.
Rujiwetpongstorn R, Chuamanochan M, Tovanabutra N, Chaiwarith R, Chiewchanvit S. Efficacy of acitretin in the treatment of reactive neutrophilic dermatoses in adult-onset immunodeficiency due to interferon-gamma autoantibody. J Dermatol. 2020;47:563–8.PubMedPubMedCentralCrossRef
160.
161.
Chiewchanvit S, Jamjanya S, Rattanathammethee T, Mahanupab P, Tovanabutra N, Chuamanochan M. Bullous Sweet syndrome in a patient with acute myeloid leukemia treated with midostaurin: rapid response to acitretin and colchicine—a case report. Dermatol Ther. 2021;e15171. https://​doi.​org/​10.​1111/​dth.​15171.
162.
Calabrese L, Caldarola G, Peris K, De Simone C. Recalcitrant Sweet syndrome successfully treated with adalimumab. J Dtsch Dermatol Ges. 2021;19:122–4.PubMed
163.
Patel AV, Jotwani PM, Sultan KS. Azathioprine-induced Sweet syndrome treated with infliximab. Am J Ther. 2019;26:e616–7.PubMedCrossRef
164.
Shahid Z, Kalayanamitra R, Patel R, Groff A, Jain R. Refractory sweet syndrome treated with anakinra. Cureus. 2019;11:e4536.PubMedPubMedCentral
165.
de Risi-Pugliese T, Seksik P, Bouaziz J-D, Chasset F, Moguelet P, Gornet J-M, et al. Ustekinumab treatment for neutrophilic dermatoses associated with Crohn’s disease: a multicenter retrospective study. J Am Acad Dermatol. 2019;80:781–4.PubMedCrossRef
166.
167.
Dubertret L, Lebreton C, Touraine R. Inhibition of neutrophil migration by etretinate and its main metabolite. Br J Dermatol. 1982;107:681–5.PubMedCrossRef
168.
Passet M, Lepelletier C, Vignon-Pennamen M-D, Chasset F, Hirsch P, Battistella M, et al. Next-generation sequencing in myeloid neoplasm-associated sweet’s syndrome demonstrates clonal relation between malignant cells and skin-infiltrating neutrophils. J Invest Dermatol. 2020;140:1873-1876.e5.PubMedCrossRef
169.
Diehl S, Rincón M. The two faces of IL-6 on Th1/Th2 differentiation. Mol Immunol. 2002;39:531–6.PubMedCrossRef
170.
171.
Brys AK, Cox SE. Early-onset sweet-like dermatitis after facial hyaluronic acid filler injection. Dermatol Surg. 2020;46:1759–61.PubMedCrossRef
172.
Flanagan KE, Krueger S, Amano S, Auerbach A, St John J, Deng A. Sweet syndrome with perifollicular involvement because of koebnerization from facial hair plucking. J Cutan Pathol. 2021;48:1189–92.PubMedCrossRef
173.
Eid E, Safi R, El Hasbani G, Aftimos V, Abbas O, Kibbi A-G, et al. Characterizing the presence of neutrophil extracellular traps in neutrophilic dermatoses. Exp Dermatol. 2021;30:988–94.PubMedCrossRef
174.
Walterscheid B, Nguyen J, Tarbox M, Eshak N. Clopidogrel-induced sweet syndrome: severe dermatological complication after percutaneous coronary intervention. Eur Heart J. 2021;42:2610.PubMedCrossRef
175.
Mattis DM, Limova M, Mully T. Dapagliflozin-induced sweet syndrome. Cutis. 2019;104:E22–4.PubMed
176.
177.
Suyama T, Ito S, Shinagawa A. Ixazomib-induced Sweet’s syndrome. Int J Hematol. 2020;111:161–2.PubMedCrossRef
178.
179.
180.
181.
Cardoso D, Coelho A, Fernandes L, Matos LV, Serrano I, Miranda H, et al. Sweet’s syndrome induced by aromatase inhibitor in the treatment of early breast cancer. Eur J Case Rep Intern Med. 2020;7:001435.PubMedPubMedCentral
182.
Zhang W, Wei S, Peng X, Xie S, Zeng K, Lai K. Proliferative Sweet syndrome associated with pregnancy and low-molecular-weight heparin sodium. Scand J Rheumatol. 2019;48:428–9.PubMedCrossRef
183.
Alkassis S, Rizwan A, Daoud L, Chi J. Midostaurin-induced Sweet syndrome in a patient with FLT3-ITD-positive AML. BMJ Case Rep. 2021;14:e243615.PubMedCrossRef
184.
Fustà-Novell X, Morgado-Carrasco D, García-Herrera A, Bosch-Amate X, Martí-Martí I, Carrera C. Palbociclib-induced histiocytoid Sweet syndrome. Clin Exp Dermatol. 2021;46:348–50.PubMedCrossRef
185.
Korkmaz M, Eryılmaz MK, Karaağaç M, Demirkıran A, Araz M, Artaç M. Pemetrexed-induced Sweet Syndrome: First case report in the medical literature. J Oncol Pharm Pract. 2021;27:1307–10.PubMedCrossRef
186.
Jiang M, Tran AK, Marshman G. A neutrophilic dermatosis following treatment of myelofibrosis with ruxolitinib: an emerging phenomenon? Australas J Dermatol. 2021;62:e607–9.PubMed
187.
Majid I, Mearaj S. Sweet syndrome after Oxford-AstraZeneca COVID-19 vaccine (AZD1222) in an elderly female. Dermatol Ther. 2021;34:e15146.PubMedCrossRef
188.
Torrealba-Acosta G, Martin JC, Huttenbach Y, Garcia CR, Sohail MR, Agarwal SK, et al. Acute encephalitis, myoclonus and Sweet syndrome after mRNA-1273 vaccine. BMJ Case Rep. 2021;14:e243173.PubMedPubMedCentralCrossRef
189.
190.
Capassoni M, Ketabchi S, Cassisa A, Caramelli R, Molinu AA, Galluccio F, et al. AstraZeneca (AZD1222) COVID-19 vaccine-associated adverse drug event: a case report. J Med Virol. 2021;93:5718–20.PubMedPubMedCentralCrossRef
191.
Darrigade A-S, Théophile H, Sanchez-Pena P, Milpied B, Colbert M, Pedeboscq S, et al. Sweet syndrome induced by SARS-CoV-2 Pfizer-BioNTech mRNA vaccine. Allergy. 2021;76:3194–6.PubMedCrossRef
192.
Bürgler C, Vinay K, Häfliger S, Klötgen H-W, Yawalkar N. Infliximab reduces activated myeloid dendritic cells, different macrophage subsets and CXCR3-positive cells in granuloma annulare. J Dermatol. 2019;46:808–11.PubMedCrossRef
Metadata
Title
New Practical Aspects of Sweet Syndrome
Authors
Tejas P. Joshi
Sarah K. Friske
David A. Hsiou
Madeleine Duvic
Publication date
14-02-2022
Publisher
Springer International Publishing
Published in
American Journal of Clinical Dermatology / Issue 3/2022
Print ISSN: 1175-0561
Electronic ISSN: 1179-1888
DOI
https://doi.org/10.1007/s40257-022-00673-4

Other articles of this Issue 3/2022

American Journal of Clinical Dermatology 3/2022 Go to the issue

Review Article

Patient and Public Involvement in Dermatology Research: A Review

Correction

Correction to: The PROVe Study: US Real-World Experience with Chlormethine/Mechlorethamine Gel in Combination with Other Therapies for Patients with Mycosis Fungoides Cutaneous T-Cell Lymphoma

Systematic Review

Effect of Vitamin D Serum Levels and Supplementation on Atopic Dermatitis: A Systematic Review and Meta-analysis

Correction

Correction to: A Review of Existing Therapies for Actinic Keratosis: Current Status and Future Directions

Review Article

Cutaneous Manifestations of SARS-CoV-2 Infection

Original Research Article

Determinants and Effectiveness of BNT162b2 mRNA Vaccination Among Patients with Atopic Dermatitis: A Population-Based Study